vardenafil-dihydrochloride and Ureteral-Obstruction

The aim of the present study was to evaluate the effects of phosphodiesterase 5 inhibitors on renal tubular apoptosis and also on expressions of endothelial and inducible nitric oxide synthases (eNOS and iNOS) in the ipsilateral kidney after partial unilateral ureteral obstruction (PUUO) in a rat model. Forty Wistar albino rats were divided into five groups. In Groups 1-4, left experimental PUUO was created. Sildenafil, vardenafil, and tadalafil were administrated to the rats of Groups 2-4, respectively. The pills were orally given to the rats for 30 days. Group 5 was defined as sham. After 30 days, all rats were sacrificed, and nephrectomy was performed. The renal specimens were examined histopathologically. Left hydroureteronephrosis was observed in Groups 1-4. Mean apoptotic cell count and eNOS and iNOS levels were significantly increased in Group 1 when compared with the other groups. The rats in Groups 2-4 showed significantly decreased apoptotic cell count and eNOS and iNOS values in the renal tubular tissue in accordance with Group 1 (p<0.05). There were significant differences in apoptotic cell counts between sildenafil group and the other two study groups. The sildenafil group demonstrated lesser apoptotic cell count than the vardenafil (p=0.021) and tadalafil (p=0.009) groups. PUUO increases the renal tubular apoptosis and elevates NOS concentrations in renal tubular tissue after PUUO. Phosphodiesterase 5 inhibitors have a protective effect against the tubular apoptosis.

Topics: Animals; Apoptosis; Carbolines; Ceftriaxone; Imidazoles; Kidney Tubules; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Ureteral Obstruction; Vardenafil Dihydrochloride

To determine the effects of phosphodiesterase isoenzyme 5 (PDE5) inhibitors upon ureteropelvic junction obstruction (UPJO) in rabbits.. Twenty-four New Zealand rabbits were randomly divided into three groups: sham-operated animals (group A; right-sided operations comprised subgroup A1 and left-sided operations comprised subgroup A2), operated animals (group B) and operated animals that received vardenafil (group C). The right-sided junctions of group A (A1) were not exposed, and therefore made up the control group. The UPJO model was established by partial obstruction of the left junction. Intravenous pyelograms were performed before and after the operation. HE staining and microscopic examinations were performed to chart the pathological changes. Immunohistochemistry (streptavidin peroxidase) was used to test the expression of TGF-beta1 and nNOS in the junctions. RT-PCR detected mRNA expression of TGF-beta1.. We observed serious hydronephrosis in group B and moderate hydronephrosis in group C, but not in group A. We also observed large pathological changes in group B, but little change in group C and no change in subgroups A1 and A2. The level of TGF-beta1 in group B was significantly higher than in groups A and C; group C expressed more TGF-beta1 than group A. More nNOS was detected in group C than group B, although the two groups both expressed nNOS at lower levels than group A.. More TGF-beta1 and less nNOS are expressed when the junction is obstructed. PDE5 inhibitors may be able to regulate these 2 factors, or other factors that have not been discussed in this experiment, in order to halt the progression of UPJO.

Topics: Animals; Imidazoles; Isoenzymes; Kidney Pelvis; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Rabbits; Sulfones; Triazines; Ureteral Obstruction; Vardenafil Dihydrochloride